| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| V De Leo, F Franchi, S Danero, M G Ricci, S La Marca, T M Urbani, M L Pieroni, N D'Antona, A R Genazzan. [Various aspects of dopaminergic function in patients with prolactin-secreting hypophyseal adenoma]. Bollettino della Societa italiana di biologia sperimentale. vol 59. issue 12. 1984-04-27. PMID:6671047. |
some authors retain that l-dopa (ld) stimulation test after pretreatment with carbidopa (cd), a dopa decarboxylase inhibitor substance, may reveal the presence of a central dopamine (da) defect in patient with prolactinoma. |
1984-04-27 |
2023-08-12 |
human |
| K Chihara, J Iwasaki, N Minamitani, H Kaji, H Kodama, T Fujita, K Shirataki, N Tamaki, S Matsumot. Prolactin secretion from human prolactinomas perifused in vitro: effect of TRH, prostaglandin E1, theophylline, dopamine and dopamine receptor blockers. Acta endocrinologica. vol 105. issue 1. 1984-03-02. PMID:6421041. |
prolactin secretion from human prolactinomas perifused in vitro: effect of trh, prostaglandin e1, theophylline, dopamine and dopamine receptor blockers. |
1984-03-02 |
2023-08-12 |
human |
| K Chihara, J Iwasaki, N Minamitani, H Kaji, H Kodama, T Fujita, K Shirataki, N Tamaki, S Matsumot. Prolactin secretion from human prolactinomas perifused in vitro: effect of TRH, prostaglandin E1, theophylline, dopamine and dopamine receptor blockers. Acta endocrinologica. vol 105. issue 1. 1984-03-02. PMID:6421041. |
to clarify the functional characteristics of prolactin (prl)-producing adenoma cells, the effect of trh, prostaglandin e1 (pge1), theophylline, dopamine and dopaminergic antagonists on prl secretion was examined in vitro in perifused pituitary adenoma tissues obtained at surgery from 8 patients with prolactinoma. |
1984-03-02 |
2023-08-12 |
human |
| K Chihara, J Iwasaki, N Minamitani, H Kaji, H Kodama, T Fujita, K Shirataki, N Tamaki, S Matsumot. Prolactin secretion from human prolactinomas perifused in vitro: effect of TRH, prostaglandin E1, theophylline, dopamine and dopamine receptor blockers. Acta endocrinologica. vol 105. issue 1. 1984-03-02. PMID:6421041. |
when perifused simultaneously with dopamine, sulpiride (d2-selective dopamine receptor blocker, 5 x 10(-7) m) blocked the inhibitory effect of dopamine on prl release in 3 of the 4 dopamine-sensitive prolactinomas. |
1984-03-02 |
2023-08-12 |
human |
| D Tater, G Charpentier, G Besson, G Rosselin, J P Bercovic. [VIP removes the inhibition of prolactin secretion induced by dopamine in patients with prolactinoma]. Comptes rendus des seances de l'Academie des sciences. Serie III, Sciences de la vie. vol 297. issue 6. 1984-02-28. PMID:6420004. |
[vip removes the inhibition of prolactin secretion induced by dopamine in patients with prolactinoma]. |
1984-02-28 |
2023-08-12 |
Not clear |
| D Tater, G Charpentier, G Besson, G Rosselin, J P Bercovic. [VIP removes the inhibition of prolactin secretion induced by dopamine in patients with prolactinoma]. Comptes rendus des seances de l'Academie des sciences. Serie III, Sciences de la vie. vol 297. issue 6. 1984-02-28. PMID:6420004. |
prl responsitivity after vaso-active intestinal peptide (vip) infusion was studied during a dopamine (da) infusion, in normal women and women with a prolactinoma. |
1984-02-28 |
2023-08-12 |
Not clear |
| R H Marti. Metoclopramide challenge: a measure of human lactotroph activity. Obstetrics and gynecology. vol 62. issue 6. 1983-12-17. PMID:6633994. |
comparison of physiologically hyperprolactinemic subjects (lactating women) with pathological ones (prolactinomas) suggests that the main mode of metoclopramide's prolactin-releasing action is mediated via dopamine antagonism, though a small direct action on the lactotroph is possible. |
1983-12-17 |
2023-08-12 |
human |
| F Massara, F Camanni, M Martra, G C Dolfin, E E Müller, G M Molinatt. Reciprocal pattern of the TSH and PRL responses to dopamine receptor blockade in women with physiological or pathological hyperprolactinaemia. Clinical endocrinology. vol 18. issue 2. 1983-07-08. PMID:6851194. |
the tsh and prl responses to administration of the two dopamine (da) receptor antagonists sulpiride and domperidone, were studied in fifteen normoprolactinaemic subjects, twenty-two post-partum women and sixteen subjects with presumptive evidence of (six subjects) or surgically confirmed (ten subjects) prolactinomas. |
1983-07-08 |
2023-08-12 |
human |
| E Reschini, C Ferrari, M Peracchi, R Fadini, M Meschia, P G Crosignan. Effect of dopamine infusion on serum prolactin concentration in normal and hyperprolactinaemic subjects. Clinical endocrinology. vol 13. issue 6. 1981-07-20. PMID:7226569. |
since intravenously infused dopamine is believed to inhibit prolactin secretion by acting at pituitary level, it is suggested that a normal functioning of pituitary dopamine receptors is maintained in most human prolactinomas. |
1981-07-20 |
2023-08-12 |
human |